Azithromycin versus erythromycin infusions prior to endoscopy in upper gastrointestinal bleeding
Author(s) -
Danny Issa,
Sanjeev Solomon,
Jonathan Hillyard,
Brian Di Pace,
Christopher Young,
Patricia A. Uber,
Adam Šíma,
Reem Z. Sharaiha,
George Smallfield
Publication year - 2021
Publication title -
translational gastroenterology and hepatology
Language(s) - English
Resource type - Journals
ISSN - 2415-1289
DOI - 10.21037/tgh-20-51
Subject(s) - medicine , azithromycin , erythromycin , endoscopy , surgery , gastroenterology , antibiotics , microbiology and biotechnology , biology
Upper gastrointestinal bleeding (GIB) is a common medical condition that is associated with substantial morbidity and mortality (1). It accounts for more than 250,000 hospitalizations annually in the United States, contributing to a significant burden and health costs (2). Despite the remarkable advances in diagnostic and therapeutic modalities, mortality rates of upper GIB continues to be Original Article
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom